New Houston accelerator leader dives into first cohort

HOUSTON INNOVATORS PODCAST EPISODE 83

Kate Evinger joins the Houston Innovators Podcast to discuss the latest from gBETA Houston. Photo courtesy of gBETA

Everything's bigger in Texas, but Kate Evinger is focused on zeroing in on a small group of startups to help them in a Texas-sized way.

As director of gBETA Houston, Evinger says the program, which expanded to Houston in 2019, is geared toward supporting companies as they navigate the initial challenges of starting a company.

"We look at early-stage companies, so those that are pre-seed or seed-stage that are looking for mentorship or support," Evinger says on this week's episode of the Houston Innovators Podcast, "and we help get to that next step whether that's to raise an upcoming round or if they are looking to get into an equity-based accelerator program."

The program runs two 7-week cohorts a year — and only five companies join each round. This tight-knit group is to the cohort's advantage, Evinger says.

"It's a very small group that we bring in, and we do this very purposefully, because we like to use a concierge approach, meaning that we tailor the experience to each of the five company's personal goals," she explains.

This week, gBETA Houston announced the latest cohort's member companies, which includes five Houston-based companies: Veza, Upbrainery, FareUpThere, Custodian Corp., and Clyr.

The program, which is a part of Wisconsin-based gener8tor, began May 6 and concludes July 7 with a pitch day. The local operation is housed out of the Downtown Launchpad alongside Impact Hub Houston and MassChallenge Texas.

"The Downtown Launchpad is a phenomenal space," Evinger says. "It's a really amazing collaborative ecosystem for our companies to be able to leverage."

Evinger shares more about the new cohort growth and gener8tor's other opportunities on the episode. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


gBETA Houston, which is based out of Downtown Launchpad, has announced its latest cohort. Photo courtesy of the Downtown Launchpad

Global accelerator announces 5 startups to its Houston cohort

early-stage support

Five Houston companies have been tapped to participate in a Houston-based, early-stage startup accelerator with a national presence.

The accelerator, gBETA, selected the five Houston companies out of over 85 applicants. The cohort represents industries like education, travel, and fintech. The summer program launched on May 6 and will take place over seven weeks before concluding on July 7 at the gBETA Houston Pitch Night.

Here are the five startups selected from Houston:

  • Clyr, led by CEO and Co-founder Jeff Jensen, makes pools smarter and more sustainable through its eco-friendly approach. Clyr connects users with their pools through the first ever solar-powered WiFi-connected Smart Skimmer device and automates pool care using renewable resources. Since launching in 2020, Clyr is located in hundreds of pools across the US and has analyzed over 2 million pool chemistry data points and given over 100,000 recommendations for fixes.
  • Custodian Corp's software-as-a-service platform solves the data management and valuation pain points of venture capital and private equity managers faster and at a fairer price than competitors. Led by CEO Federico Jost, Custodian's main product is the CPMTOOL, a cloud-based solution to collect, aggregate, organize and analyze portfolio company data for monitoring and reporting purposes. Custodian launched in January of 2021, has six pilots to date and has tripled revenue since February of 2021.
  • FareUpThere's travel platform takes the mystery out of booking the perfect flight. Led by CEO and Co-Founder Malcolm Woods, FareUpThere's restaurant-style menu of flight amenities allows passengers to easily customize their perfect flight ranging from exact inches of legroom to whether the flight has Netflix. FareUpThere successfully launched a private beta in December of 2020.
  • UpBrainery, led by CEO and Founder Ghazal Qureshi, created a marketplace provides an AI-driven software platform and research-based, results-driven curriculum to students, parents, teachers and organizations. UpBrainery's journey mapping tool aligns a students educational interests and learning styles with their goals to visualize the steps needed to achieve them. Since launching in March of 2020, UpBrainery has provided over 5,000 students with opportunities for digital learning and customers include Whataburger, Girl Scouts and The Houston Rockets.
  • Veza, Launched in December, connects the world's influencer marketing experts through its professional social network. Veza's network supports both sides of the influencer marketing industry; the businesses searching for talent and the influencers looking for opportunities. Led by CEO Efrain Batista, Veza offers businesses access to the world's first free influencer search and discovery platform.

The program, which has been operating online due to the pandemic, has its local office in the Downtown Launchpad.

"Downtown Launchpad starts at the edge of technology and entrepreneurship, where cutting-edge ideas can quickly be explored, and future technology can become high-impact businesses. It was developed around a framework of resources to help entrepreneurs as they seamlessly navigate through the stages of startup production," says Robert Pieroni, director of Economic Development of Central Houston, in the release.

The free accelerator is a part of Madison, Wisconsin-based gener8tor's suite of accelerators, and announced its plan to launch in Houston in September 2019. The program's inaugural cohort premiered in May and conducted the first program this summer completely virtually. The second cohort took place last fall.

"In order to harness the impact of entrepreneurs and innovators of new technologies, an ecosystem involving many parts is needed," continues Pieroni. "That is why we recruited the nationally acclaimed startup accelerator, gener8tor, to our city. We're thrilled that gener8tor is one of Downtown Launchpad's resident partners and are helping us continue our mission to inspire innovation in the Houston community. I look forward to the impact created by the startups in this year's cohort."

Kate Evinger leads the local program as director. She recently assumed this role, and this will be her first cohort to direct.

"Houston is at a pivotal moment in time with the exciting innovations taking place in the ecosystem," says Evinger in the release. "I'm thrilled to be a part of the Houston community supporting the work of these incredible founders in the gBETA Houston Summer 2021 program."

Stream a recent episode of the Houston Innovators Podcast where Evinger shares what she's excited about for this cohort:

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”